These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8101537)

  • 1. Mechanisms of cytotoxicity used by human peripheral blood CD4+ and CD8+ T cell subsets. The role of granule exocytosis.
    Smyth MJ; Ortaldo JR
    J Immunol; 1993 Jul; 151(2):740-7. PubMed ID: 8101537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
    Smyth MJ; Norihisa Y; Ortaldo JR
    J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and cytotoxic profile of human peripheral blood CD4+ T lymphocytes.
    Smyth MJ
    Immunol Cell Biol; 1992 Dec; 70 ( Pt 6)():379-90. PubMed ID: 1363236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes.
    Lancki DW; Hsieh CS; Fitch FW
    J Immunol; 1991 May; 146(9):3242-9. PubMed ID: 1673149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW; Kaper BP; Fitch FW
    J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of two distinct cytolytic mechanisms among murine CD4 subsets.
    Ju ST; Ruddle NH; Strack P; Dorf ME; DeKruyff RH
    J Immunol; 1990 Jan; 144(1):23-31. PubMed ID: 1967264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.
    Wong JT; Pinto CE; Gifford JD; Kurnick JT; Kradin RL
    J Immunol; 1989 Nov; 143(10):3404-11. PubMed ID: 2509557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted cytotoxic cells in human peripheral blood lymphocytes.
    Garrido MA; Perez P; Titus JA; Valdayo MJ; Winkler DF; Barbieri SA; Wunderlich JR; Segal DM
    J Immunol; 1990 Apr; 144(8):2891-8. PubMed ID: 1691221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic inhibitors distinguish cytolytic activity of CD4 and CD8 clones.
    Strack P; Martin C; Saito S; Dekruyff RH; Ju ST
    Eur J Immunol; 1990 Jan; 20(1):179-84. PubMed ID: 1968392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cytotoxic T cell lysis by anti-CD8 monoclonal antibodies: studies with CD3-targeted cytolysis of nominal antigen-negative targets.
    Quinones RR; Segal DM; Henkart P; Perez P; Gress RE
    J Immunol; 1989 Apr; 142(7):2200-6. PubMed ID: 2466891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal requirement for induction of MHC-unrestricted antitumor cytotoxicity of human T cell CD4+/CD8+ subpopulations.
    Zhu HG; Klein-Franke A; Anderer FA
    Anticancer Res; 1994; 14(3A):953-61. PubMed ID: 8074498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture.
    Rangel R; Rocha L; Ramirez JL; Ibarra MJ; Solorza G; Monroy A; Ramirez MA; Herrera A; Weiss-Steider B
    Eur Cytokine Netw; 1995; 6(3):195-202. PubMed ID: 8589277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to CD44 trigger effector functions of human T cell clones.
    Galandrini R; Albi N; Tripodi G; Zarcone D; Terenzi A; Moretta A; Grossi CE; Velardi A
    J Immunol; 1993 May; 150(10):4225-35. PubMed ID: 8097750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of cytotoxicity used by human peripheral blood T-cell subsets.
    Smyth MJ
    Transplant Proc; 1992 Oct; 24(5):2321-2. PubMed ID: 1329291
    [No Abstract]   [Full Text] [Related]  

  • 15. Human CD8+ T lymphocytes can be divided into CD45RA+ and CD45RO+ cells with different requirements for activation and differentiation.
    de Jong R; Brouwer M; Miedema F; van Lier RA
    J Immunol; 1991 Apr; 146(7):2088-94. PubMed ID: 1826015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.
    Lewinsohn DM; Bement TT; Xu J; Lynch DH; Grabstein KH; Reed SG; Alderson MR
    J Immunol; 1998 Mar; 160(5):2374-9. PubMed ID: 9498779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TNF-alpha in CD8+ cytotoxic T lymphocyte-mediated lysis.
    Ratner A; Clark WR
    J Immunol; 1993 May; 150(10):4303-14. PubMed ID: 8482837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of primary T lymphocytes results in lysosome development and polarized granule exocytosis in CD4+ and CD8+ subsets, whereas expression of lytic molecules confers cytotoxicity to CD8+ T cells.
    Shen DT; Ma JS; Mather J; Vukmanovic S; Radoja S
    J Leukoc Biol; 2006 Oct; 80(4):827-37. PubMed ID: 16891618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of two distinct killing mechanisms in bystander target cell lysis induced by a cytotoxic T lymphocyte clone.
    Kuwano K; Arai S
    Cell Immunol; 1996 May; 169(2):288-93. PubMed ID: 8620557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation of CD8+ T cells by transforming growth factor-beta 1.
    Lee HM; Rich S
    J Immunol; 1993 Jul; 151(2):668-77. PubMed ID: 8335902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.